Bell Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.63M Sell
2,269
-1,092
-32% -$1.29M 0.95% 41
2026
Q2
$4.03M Buy
3,361
+642
+24% +$656K 1.08% 33
2026
Q1
$2.5M Sell
2,719
-315
-10% -$319K 0.74% 55
2025
Q4
$3.28M Sell
3,034
-4,072
-57% -$3.89M 0.88% 52
2025
Q3
$5.42M Sell
7,106
-4,248
-37% -$3.16M 1.48% 17
2025
Q2
$8.85M Buy
11,354
+877
+8% +$681K 1.95% 9
2025
Q1
$8.65M Buy
10,477
+4,840
+86% +$4.03M 1.59% 17
2024
Q4
$4.35M Buy
+5,637
New +$4.67M 0.79% 58

Other funds holding LLY

Bell Asset Management's LLY Position: Q3 2026 in Review

Bell Asset Management reduced its Eli Lilly (LLY) stake by 32% in Q3 2026, selling an estimated $1.29M and leaving 2,269 shares worth $2.63M. The position accounts for 0.95% of the portfolio, ranked #41.

Bell Asset Management first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. The position peaked at $8.85M in Q2 2025. 3,049 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Bell Asset Management held 2,269 shares of Eli Lilly worth $2.63M as of Q3 2026.
  • Bell Asset Management sold 1,092 Eli Lilly shares in Q3 2026, an estimated $1.29M.
  • Eli Lilly made up 0.95% of Bell Asset Management's portfolio in Q3 2026, its #41 holding.
  • Bell Asset Management first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
  • Bell Asset Management's Eli Lilly position peaked at $8.85M in Q2 2025.
  • 3,049 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Bell Asset Management's 13F filing for Q3 2026, filed 8 Oct 2026.